CLINICAL_TRIALS
other
· 2025-06-06
Clinical Trial Update: Telitacicept for the Treatment of Refractory RA [Phase 4]
Summary
A Phase 4 clinical trial evaluating Telitacicept for refractory rheumatoid arthritis is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese SLE Treatment And Research Group | Conditions: Rheumatoid Arthritis (RA) | Phase 4 | Status: NOT_YET_RECRUITING